已收盤 09-11 16:00:00 美东时间
0.000
0.00%
本文不构成任何投资意见和建议,以官方/公司公告为准;本文仅作医疗健康相关药物介绍,非治疗方案推荐(若涉及),不代表平台立场。任何文章转载需得到授权。 新锐自免...
05-20 09:34
Mr. Bonney brings more than three decades of leadership experience in the biopharmaceutical industry, including significant expertise in multiple sclerosis (MS) and broader central nervous system markets. Notably, during
05-19 18:32
Dianthus Therapeutics press release (NASDAQ:DNTH): Net loss for the year ended December 31, 2023 was $43.6 million or $8.45 net loss per share (basic and diluted) compared to $28.5 million or $32.57 ...
2024-03-22 05:16
真正的离开,从来都是悄无声息的。 据智药局监测,2023年全球至少有16条ADC临床管线终止研发,涉及9家药企,这些管线悄悄从官网消失了,同时并未出现公开转让或...
2023-12-19 18:57
Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study in acromegaly.
2023-09-12 01:38
转自:药时空 ADC的火热刺激着一批又一批玩家进场,一方面市场对于药企试错的容忍度不断降低,对药物的安全性和疗效提出了更高要求。 另一方面,对企业而言,药物未...
2023-08-13 00:01
NEW YORK, May 4, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or b...
2023-05-04 12:00
Magenta Therapeutics Inc (NASDAQ: MGTA) and privately-held Dianthus Therapeutics Inc have announced to merge in an
2023-05-04 02:19
Gainers Immunogen (NASDAQ:IMGN) shares rose 126.1% to $11.76 during Wednesday'...
2023-05-04 01:31
Magenta Therapeutics, Inc. (NASDAQ: MGTA) ("Magenta") and Dianthus Therapeutics, Inc.
2023-05-03 19:34